Clinical trial
A Randomized, Placebo Controlled Study on the Efficacy of Itopride HCI on Irritable Bowel in Patients of Irritable Bowel Syndrome With Constipation (IBS-C)
NCT01027260 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo Controlled Study on the Efficacy of Itopride HCI on Irritable Bowel in Patients of Irritable Bowel Syndrome With Constipation (IBS-C)
- Lead sponsor
- Abbott
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2008
- Completion date
- September 30, 2010
- Enrollment
- 268 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.